Neil Belenkie has been appointed chief executive officer of Sirona Biochem Corp. Dr. Howard Verrico will remain chairman of the board.
“Neil Belenkie brings to Sirona Biochem the experience, determination and network we need to accelerate growth,” said Dr. Dr. Verrico, Sirona Biochem’s founder and chairman of the board. “Sirona Biochem’s programs have matured from scientific concepts to compounds showing commercial potential. It’s the right time to welcome Neil Belenkie’s leadership to Sirona Biochem to propel these programs forward.”
Neil Belenkie, a winner of Business in Vancouver Magazine’s Top 40 Under 40, brings his significant healthcare experience to Sirona Biochem. Mr. Belenkie’s career in life sciences includes leadership roles in sales, market research, marketing, and medical education. He is the founder of strategic management consulting company GrowthPoint Group, which provides business solutions for long-term growth. His life sciences background includes leadership roles at Ortho Biotech and Hoffman LaRoche.